FDA Drug recall D-0763-2022
SYMJEPI (epinephrine injection, USP) 0.3 mg, (0.3 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Ada…
- FDA Drug
- Class I
- terminated
- Published 2022-04-13
On 2022-04-13 the FDA classified a Class I recall of SYMJEPI (epinephrine injection, USP) 0.3 mg, (0.3 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Ada… by Adamis Pharmaceuticals, citing defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0763-2022 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2022-03-21 |
| Published | 2022-04-13 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Adamis Pharmaceuticals |
| Distribution | US |
Product
SYMJEPI (epinephrine injection, USP) 0.3 mg, (0.3 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-130-02
Reason
Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
Identifiers
| code_info | Lot #: 21041W, Exp. 8/31/2022; 21081W, Exp. 11/30/2022; 21102W, Exp. 2/28/2023 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0763-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.